Towerpoint Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
Towerpoint Wealth's ABBV Position: Q2 2026 in Review
Towerpoint Wealth increased its AbbVie (ABBV) stake by 1.8% in Q2 2026, buying an estimated $18.5K and bringing the position to 4,871 shares worth $1.23M. The position accounts for 0.42% of the portfolio, ranked #42.
Towerpoint Wealth first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. 1,742 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Towerpoint Wealth held 4,871 shares of AbbVie worth $1.23M as of Q2 2026.
- Towerpoint Wealth bought 86 AbbVie shares in Q2 2026, an estimated $18.5K.
- AbbVie made up 0.42% of Towerpoint Wealth's portfolio in Q2 2026, its #42 holding.
- Towerpoint Wealth first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
- 1,742 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Towerpoint Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.